Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $17.25M Series A (Feb 2026) led by Khosla Ventures with Keith Rabois on board — Khosla's first investment in a Brazilian company. Clients include Nubank and QuintoAndar.
Comp AI is an AI-native compensation and performance management platform that positions itself as an alternative to legacy compensation consultancies like Mercer and Korn Ferry — providing real-time market compensation benchmarking, equity planning, and performance calibration through software rather than expensive human consulting engagements. The company raised $17.25 million in Series A financing in February 2026, led by Khosla Ventures with Keith Rabois joining the board — representing Khosla's first investment in a Brazilian company.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.